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The eVALuate study: two parallel randomised trials, one comparing
laparoscopic with abdominal hysterectomy, the other comparing
laparoscopic with vaginal hysterectomy
Ray Garry, Jayne Fountain, Su Mason, Vicky Napp, Julia Brown, Jeremy Hawe, Richard Clayton, Jason Abbott, Graham
Phillips, Mark Whittaker, Richard Lilford, Stephen Bridgman
Abstract
Objective To compare the effects of laparoscopic hysterectomy
and abdominal hysterectomy in the abdominal trial, and
laparoscopic hysterectomy and vaginal hysterectomy in the
vaginal trial.
Design Two parallel, multicentre, randomised trials.
Setting 28 UK centres and two South African centres.
Participants 1380 women were recruited; 1346 had surgery;
937 were followed up at one year.
Primary outcome Rate of major complications.
Results In the abdominal trial laparoscopic hysterectomy was
associated with a higher rate of major complications than
abdominal hysterectomy (11.1% v 6.2%, P = 0.02; difference
4.9%, 95% confidence interval 0.9% to 9.1%) and the number
needed to treat to harm was 20. Laparoscopic hysterectomy
also took longer to perform (84 minutes v 50 minutes) but was
less painful (visual analogue scale 3.51 v 3.88, P = 0.01) and
resulted in a shorter stay in hospital after the operation (3 days
v 4 days). Six weeks after the operation, laparoscopic
hysterectomy was associated with less pain and better quality of
life than abdominal hysterectomy (SF-12, body image scale, and
sexual activity questionnaires).
In the vaginal trial we found no evidence of a difference in
major complication rates between laparoscopic hysterectomy
and vaginal hysterectomy (9.8% v 9.5%, P = 0.92; difference
0.3%, − 5.2% to 5.8%), and the number needed to treat to harm
was 333. We found no evidence of other differences between
laparoscopic hysterectomy and vaginal hysterectomy except
that laparoscopic hysterectomy took longer to perform (72
minutes v 39 minutes) and was associated with a higher rate of
detecting unexpected pathology (16.4% v 4.8%, P = < 0.01).
However, this trial was underpowered.
Conclusions Laparoscopic hysterectomy was associated with a
significantly higher rate of major complications than abdominal
hysterectomy. It also took longer to perform but was associated
with less pain, quicker recovery, and better short term quality of
life. The trial comparing vaginal hysterectomy with laparoscopic
hysterectomy was underpowered and is inconclusive on the rate
of major complications; however, vaginal hysterectomy took less
time.
Introduction
In 1996 Stovall and Summitt concluded that well designed clini-
cal trials examining short term outcomes, economics, and qual-
ity of life were required to determine the role of laparoscopic
hysterectomy.1 Ten previous randomised trials have compared
outcomes for abdominal hysterectomy with laparoscopic
hysterectomy.2–11 Most of these were from single centres of endo-
scopic surgical excellence and had small study populations. Each
trial showed that laparoscopic hysterectomy was associated with
reduced hospital stay and, in most studies, a shorter time to con-
valescence and notably less pain than abdominal hysterectomy.
Oonly four previously published randomised trials have
compared the outcomes of vaginal hysterectomy and laparo-
scopic hysterectomy.12–15 The only difference shown in these
studies was that laparoscopic hysterectomy took longer to
perform.
We know of no previous trials that were powered to
investigate the safety of the various procedures. We have
therefore undertaken a concurrent pair of randomised
controlled trials to eVALuate the relative roles of Vaginal,
Abdominal, and Laparoscopic hysterectomy in routine gynaeco-
logical practice.
Methods
Design
We conducted two parallel, multicentre, randomised trials
concurrently. The first compared laparoscopic hysterectomy
with abdominal hysterectomy (abdominal trial), and the second
compared laparoscopic hysterectomy with vaginal hysterectomy
(vaginal trial). Both trials had the same management structure,
eligibility criteria, and outcome measures.
We obtained approval for recruitment in South Africa
according to local practice. An independent trial steering
committee and a data monitoring and ethics committee oversaw
the trials.
Participants
Patients who needed a hysterectomy for non-malignant
conditions were eligible; excluded were patients who had a
second or third degree uterine prolapse, a uterine mass greater
than the size of a 12 week pregnancy, a medical illness preclud-
ing laparoscopic surgery, or a requirement for bladder or other
pelvic support surgery, and patients who refused consent.
Gynaecologists were responsible for recruitment and on
clinical grounds entered patients for randomisation into either
A complete list of members of the study group is on bmj.com
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the abdominal or the vaginal trial. Follow up of patients took
place in a clinic at six weeks and then by postal questionnaire, at
four months and one year after their operation.
To minimise potential effects due to a learning curve, each
surgeon had to have performed at least 25 of each procedure.
Cases could be used for teaching, providing the main assistant
was the recruiting gynaecologist.
Interventions
Surgical procedures were as currently practised, with four
approaches to laparoscopic hysterectomy: laparoscopic hysterec-
tomy, laparoscopic assisted vaginal hysterectomy, laparoscopic
supracervical hysterectomy, and total laparoscopic hysterectomy.
All conversions were documented. Each surgeon’s practice
standardised antibiotics, analgesia, anticoagulants, anaesthetic
care, and advice concerning resumption of normal activities over
the three types of operation.
Outcome measures
The primary end point of the trials was the occurrence of at least
one major complication (box 1). Major haemorrhage was
regarded as a major complication if a blood transfusion was
required, minor otherwise; haematoma was a major complica-
tion if surgical drainage was required, minor otherwise. An inde-
pendent clinical reviewer differentiated between major and
minor anaesthetic problems. Secondary end points were minor
complications (box 2), blood loss, pain measured by a visual ana-
logue scale and analgesia requirements, and questionnaire
assessments of sexual activity,16 body image,17 and health status
(SF-12).18
Sample size
The sample size for the abdominal trial was based on detecting a
relative reduction in complication rates of 50% from 9%19; 487
patients in each arm were 80% power and 5% significance (two
sided), not corrected for continuity.19
The complication rate in the vaginal trial was expected to be
4% for vaginal hysterectomy.20 To detect a 50% reduction in this
rate, 1141 patients were required per treatment arm. As vaginal
hysterectomy was performed relatively infrequently we did not
expect to recruit this number but wanted to collect the
randomised data as this would represent the largest such trial of
vaginal hysterectomy that we are aware of.
Randomisation
We chose a 2:1 unbalanced randomisation to provide more
exposure to data on the new laparoscopic procedure and to
reduce the potential impact of any remaining learning curve,
with little loss of power. Patients were allotted to either the
abdominal or vaginal trial according to the individual surgeon’s
usual practice. Randomisation to the selected conventional
approach or laparoscopic hysterectomy alternative was made by
telephone access to a computer-generated randomisation
programme held at the Northern and Yorkshire Clinical Trials
Research Unit. We minimised randomisation by proposed trial,
surgeon, intended removal of ovaries, and body mass index ( ≤ 30
or > 30).
Statistical methods
The primary analysis was by intention to treat. We also
performed a secondary analysis of the primary end point,
according to the procedure that was started (per protocol analy-
sis).
We used 2 tests to compare the primary outcome. We also
did sensitivity analysis, assuming that patients not having an
operation would not have had a major complication, and then
assuming that they would. We used logistic regression to adjust
the major complication rate for the stratification factors of body
mass index and intended removal of the ovaries.
The analysis of minor complication rates and of the rate of
additional pathology found during the operation was the same
as for major complications. Patients recorded pain and use of
opiates in a daily diary booklet, scored on day 0 (operation day)
and then days 2, 7, and 21 after the operation. We used analysis
of covariance to adjust average pain scores over days 0-6 by the
number of days opiates were used. We calculated length of pro-
cedure as time in minutes from first incision to last suture and
length of stay as operation to day of discharge. We planned no
formal statistical testing on these times.
We assessed quality of life at randomisation; before the
operation; and six weeks, four months, and one year after the
operation. We used analysis of covariance to adjust for
prerandomisation questionnaires (baseline). For patients having
a laparoscopic hysterectomy we used a series of univariate logis-
tic regression models to identify predictors of major complica-
tions.
Results
Forty three gynaecologists from 28 UK and two South African
centres recruited 876 patients into the abdominal trial and 504
into the vaginal trial between November 1996 and September
2000. The recruitment target in the abdominal trial was
therefore not reached. The trial steering committee closed the
trials in September 2000 because funding ended and the rate of
recruitment decreased.
Demography
Baseline characteristics were well matched in each of the
allocated trials (table 1). The baseline characteristics between the
two trials differed. More than 90% of the patients allocated to the
vaginal trial had had one or more vaginal deliveries compared
with less than 85% in the abdominal trial. This distribution was
reversed for caesarean deliveries. Only one of 30 patients with
Box 1: Major complications
• Major haemorrhage (requiring transfusion)
• Haematoma requiring transfusion or surgical drainage
• Bowel injury
• Ureteric injury
• Bladder injury
• Pulmonary embolus
• Major anaesthesia problems
• Unintended laparotomy
• Wound dehiscence
Box 2: Minor complications
• Haemorrhage not requiring transfusion
• Infection: chest, urinary, wound, pelvic, other; or fever ≥ 38°C
on any single occasion
• Haematoma (spontaneous drainage)
• Deep vein thrombosis
• Cervical stump problems
• Minor anaesthesia problems
• Others
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palpable endometriosis was allocated to the vaginal trial. Patients
with pelvic pain, more than one indication for hysterectomy, a
fixed uterus, no uterine descent, or intended removal of the ova-
ries were more likely to be allocated to the abdominal trial.
The mean waiting times for the operations were similar,
about 70 days. The main indications for hysterectomy were dys-
functional uterine bleeding (874/1380 cases, 63%), fibroids (235
cases, 17%), pelvic pain (151 cases, 11%), endometriosis (126
cases, 9%), and failed ablation (104 cases, 8%).
Numbers analysed
The figure shows the flow of patients through the trials. We per-
formed a per protocol analysis as 46 (3.3%) patients were
allocated to one procedure but had an alternative operation
because of preoperative conversion (patient’s decision (25 cases,
54%) and surgeon’s unavailability (10 cases, 22%)).We undertook
sensitivity analyses for the 34 patients who did not actually have
an operation. Reasons for withdrawing preoperatively were
mainly cancelled operations (25 cases, 74%).
Primary outcome
Table 2 details the major complications. Patients had up to four
major complications. Of particular importance in the abdominal
trial were severe haemorrhage following laparoscopic hysterec-
tomy (4.6%) and abdominal hysterectomy (2.4%), as well as uret-
eric injuries in both trials. All six of the damaged ureters
occurred in the laparoscopic hysterectomy arms. Unintended
laparotomy was the second most common complication,
affecting 45 patients; of these 13 had another major
complication. The reasons given for the other conversions
included additional pathology, poor access, removal of ovarian
cyst, unable to secure haemostasis, and endometrial cancer.
In the abdominal trial significantly more patients undergoing
laparoscopic hysterectomy than patients undergoing abdominal
hysterectomy had at least one major complication (11.1% v 6.2%,
mean difference 4.9%, 95% confidence interval 0.9% to 9.1%;
odds ratio 1.91, 1.11 to 3.28). The number needed to treat to
harm was 20. In this trial the odds of having a major
complication was approximately twice as likely for patients
undergoing laparoscopic hysterectomy.
We found no difference in the complication rates after the
two procedures in the vaginal trial (9.8% for laparoscopic hyster-
ectomy, 9.5% for vaginal hysterectomy (n = 18), mean difference
0.3%, − 5.2% to 5.8%, P = 0.92; odds ratio 0.97, 0.52 to 1.81); the
number needed to treat to harm was 333. However, this trial was
not powered to detect a difference.
Per protocol and sensitivity analyses narrowed the size of dif-
ference between the types of operation for both trials, but the
difference remained in the same direction. Adjustment for strati-
fication factors made little difference to treatment effects.
Secondary outcomes
Minor complications—In the abdominal trial the percentage of
patients who had at least one minor complication was 27.1% in
patients undergoing abdominal hysterectomy compared with
25.2% for laparoscopic hysterectomy, and in the vaginal trial
27.9% for patients undergoing vaginal hysterectomy and 23.2%
for laparoscopic hysterectomy (table 3).We found no evidence to
show that there was any difference in minor complication rates
between the procedures (P > 0.05) in any of the comparisons
(intention to treat and sensitivity).
Additional pathology found during the operation—In the
abdominal trial additional pathology was reported in 12.7%
(373/292) of patients undergoing abdominal hysterectomy
compared with 22.6% (132/584) undergoing laparoscopic
hysterectomy (mean difference − 9.9%, − 15.4 to − 4.4%,
P = < 0.01). In the vaginal trial the rates were 4.8% (8/168) for
vaginal hysterectomy and 16.4% (53/336) for laparoscopic
hysterectomy (mean difference − 11.6%, − 17.7% to − 5.5%,
P = < 0.01). The main additional findings were adhesions,
endometriosis, and fibroids.
Pain—In the abdominal trial abdominal hysterectomy was
more painful than laparoscopic hysterectomy (adjusted mean
pain score 3.9 abdominal hysterectomy, 3.5 laparoscopic hyster-
ectomy; mean difference 0.4, 0.09 to 0.7, P = 0.01). A slightly
higher proportion of patients undergoing abdominal hysterec-
tomy used opiates than patients undergoing laparoscopic
hysterectomy (80% v 76%). We found no evidence of a difference
in pain scores in the vaginal trial. In this trial a higher proportion
of patients undergoing vaginal hysterectomy (71%, 119/168)
used opiates than patients undergoing laparoscopic hysterec-
tomy (62%, 209/336).
Length of surgery and length of stay—Table 4 summarises the
data for length of procedure. In the abdominal trial the median
(minimum, maximum) length of stay after abdominal hysterec-
tomy was four (1, 36) days and three (1, 36) days after
Table 1 Baseline characteristics of participants in the two trials. Values are numbers (percentages) of participants unless otherwise indicated
Characteristic
Abdominal trial Vaginal trial
Abdominal hysterectomy (n=292) Laparoscopic hysterectomy (n=584)
Vaginal hysterectomy
(n=168) Laparoscopic hysterectomy (n=336)
Mean (SD) age 41.2 (7.6) 41.7 (7.2) 40.8 (6.5) 40.9 (6.9)
Mean (SD) body mass index 25.9 (5.4) 26.6 (5.1) 26.5 (4.7) 26.4 (5.1)
Mode number of pregnancies (% ever
pregnant)
2 (90.7) 2 (91.4) 2 (95.2) 2 (96.7)
Vaginal deliveries mode (% having at
least one vaginal delivery)
2 (83.4) 2 (80.9) 2 (91.0) 2 (94.3)
Caesarean deliveries mode (% having at
least one caesarean section)
0 (16.9) 0 (19.1) 0 (9.6) 0 (10.2)
Vaginal capacity:
Narrow 14 (4.8) 32 (5.5) 8 (4.8) 7 (2.1)
Normal 275 (94.2) 549 (94.0) 157 (93.5) 322 (95.8)
Large 2 (0.7) 2 (0.3) 2 (1.2) 4 (1.2)
Palpable endometriosis 10 (3.4) 19 (3.3) 1 (0.6) 0 (0.0)
Current smoker 142 (48.6) 241 (41.3) 72 (42.9) 131 (39.0)
Previous pelvic surgery 185 (63.3) 368 (63.0) 102 (60.7) 197 (58.6)
Mean (minimum to maximum) uterine
size (expressed as equivalent to
weeks of pregnancy)
6 (0 to 12) 6 (0 to 12) 6 (0 to 12) 6 (0 to 12)
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laparoscopic hysterectomy, and in the vaginal trial three (1, 16)
days after vaginal hysterectomy and three (1, 19) days after
laparoscopic hysterectomy. In the abdominal trial only 60%
177/292of patients who underwent abdominal hysterectomy
were discharged by day 4 compared with 80% (492/584) after
laparoscopic hysterectomy; in the vaginal trial 80% of patients in
both the vaginal hysterectomy arm (135/168) and the
laparoscopic hysterectomy arm (269/336) were discharged by
day 4. We undertook no formal statistical testing, but these
differences may be clinically important.
Recruited and allocated to trial (n=1380)
Abdominal trial randomised (n=876)
Abdominal hysterectomy (n=292) Laparoscopic hysterectomy (n=584)
Vaginal trial randomised (n=504)
Vaginal hysterectomy (n=168) Laparoscopic hysterectomy (n=336)
Had allocated operation (n=268)
Withdrew before operation (n=6)
Converted before operation (n=18):
  To laparoscopic  hysterectomy
   (abdominal) (n=17)
  To vaginal hysterectomy (n=1)
Six week visit:
Follow up forms (n=275)
Lost to follow up (n=17)
Quality of life forms (n=215)
Analysed (n=174)
Lost to follow up (n=77)
Four month follow up:
Quality of life forms (n=169)
Analysed (n=161)
Lost to follow up (n=104)
Missing (n=19)
Four month follow up:
Quality of life forms (n=385)
Analysed (n=355)
Lost to follow up (n=166)
Missing (n=33)
Four month follow up:
Quality of life forms (n=102)
Analysed (n=95)
Lost to follow up (n=55)
Missing (n=11)
Four month follow up:
Quality of life forms (n=192)
Analysed (n=172)
Lost to follow up (n=118)
Missing (n=26)
One year follow up:
Quality of life forms (n=218)
Analysed (n=198)
Lost to follow up (n=118)
One year follow up:
Quality of life forms (n=113)
Analysed (n=105)
Lost to follow up (n=55)
One year follow up:
Quality of life forms (n=418)
Analysed (n=391)
Lost to follow up (n=166)
One year follow up:
Quality of life forms (n=188)
Analysed (n=172)
Lost to follow up (n=104)
Six week visit:
Follow up forms (n=555)
Lost to follow up (n=29)
Quality of life forms (n=457)
Analysed (n=359)
Lost to follow up (n=127)
Six week visit:
Follow up forms (n=158)
Lost to follow up (n=10)
Quality of life forms (n=119)
Analysed (n=95)
Lost to follow up (n=49)
Six week visit:
Follow up forms (n=309)
Lost to follow up (n=27)
Quality of life forms (n=226)
Analysed (n=173)
Lost to follow up (n=110)
Had allocated operation (n=559)
Withdrew before operation (n=11)
Converted before operation (n=14):
  To abdominal hysterectomy (n=13)
  To vaginal hysterectomy (n=1)
Had allocated operation (n=161)
Withdrew before operation (n=5)
Converted before operation (n=2):
  To laparoscopic hysterectomy
   (vaginal) (n=2)
Had allocated operation (n=312)
Withdrew before operation (n=12)
Converted before operation (n=12):
  To vaginal hysterectomy (n=10),
  To abdominal hysterectomy (n=2)
Flow of participants through the trials. Among patients whose procedures were converted, 283 underwent abdominal hysterectomies and 576 laparoscopic
hysterectomies in the abdominal trial; 173 underwent vaginal hysterectomies and 314 laparoscopic hysterectomies in the vaginal trial. Follow up forms not received
within the appropriate time frames were not included in the analysis. The time frames were 14 days at six weeks and 28 days at four months and one year
Table 2 Primary end point of both trials: major complications. Values are numbers (percentages) of participants
Abdominal trial Vaginal trial
Abdominal hysterectomy (n=292)
Laparoscopic hysterectomy
(n=584) Vaginal hysterectomy (n=168)
Laparoscopic hysterectomy
(n=336)
Major haemorrhage 7* (2.4) 27* (4.6) 5 (2.9) 17 (5.1)
Bowel injury 3 (1) 1 (0.2) 0 0
Ureteric injury 0 5 (0.9) 0 1 (0.3)
Bladder injury 3 (1) 12* (2.1) 2 (1.2) 3 (0.9)
Pulmonary embolus 2 (0.7) 1 (0.2) 0 2 (0.6)
Anaesthesia problems 0 5* (0.9) 0 2 (0.6)
Unintended laparotomy:
Intraoperative conversion 1† (0.3) 23 (3.9) 7 (4.2) 9 (2.7)
Return to theatre 1 (0.3) 3 (0.5) 0 1 (0.3)
Wound dehiscence 1 (0.3) 1 (0.2) 0 1 (0.3)
Haematoma 2 (0.7) 4 (0.7) 2 (1.2) 7 (2.1)
Other complications 0 0 (0) 1 (0.6) 0 (0)
At least one major complication 18 (6.2) 65 (11.1) 16 (9.5) 33 (9.8)
A patient may have had more than one complication.
*These patients converted procedure before the operation: one patient undergoing abdominal hysterectomy converted to laparoscopic hysterectomy before the operation in the abdominal trial
and had a major haemorrhage. Two patients in the abdominal trial who were undergoing laparoscopic hysterectomy converted to abdominal hysterectomy before the operation and had a major
haemorrhage. One patients undergoing laparoscopic hysterectomy in the abdominal trial converted to abdominal hysterectomy before the operation and had a major anaesthetic problem. One
patient undergoing laparoscopic hysterectomy in the abdominal trial converted to abdominal hysterectomy before the operation and had a bladder injury.
†This patient in the abdominal trial was randomised to abdominal hysterectomy, converted to laparoscopic hysterectomy before the operation, and then converted back to abdominal
hysterectomy during the operation.
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Quality of life—All procedures were associated with improve-
ments in the physical and mental components of SF-12, body
image scale, and aspects of sexual activity at four months
compared with baseline. These changes were maintained or
improved further at 12 months. In the abdominal trial we found
a highly significant difference in the physical component
summary score of the SF-12 at six weeks between abdominal
hysterectomy and laparoscopic hysterectomy (score − 5.1, 95%
confidence interval − 7.1 to − 3.2, P < 0.01).We also found highly
significant differences in body image scale between abdominal
hysterectomy and laparoscopic hysterectomy in the abdominal
trial at six weeks (1.5, 0.5 to 2.4, P ≤ 0.01), a borderline significant
difference at four months (1.1, 0.06 to 2.1, P = 0.06) but no differ-
ence at 12 months (table 5). According to the sexual activity
questionnaire “habit” scores in this trial were higher at six weeks
after laparoscopic hysterectomy than after abdominal hysterec-
tomy ( − 0.3, 0.1 to 0.6, P ≤ 0.01). We found no evidence of a dif-
ference in quality of life at any time point in the vaginal trial.
Predictors of major complication—Uterine descent and method
of haemostasis of the uterine the ovarian pedicles were identified
as significant predictors of major complications in patients
undergoing laparoscopic hysterectomy (table 6). The vascular
pedicles were sutured in only 7% (68/920) of cases, but this was
associated with 25% (24/98) of all major complications;
insufficient data were available to investigate this further.
Discussion
The results of the two trials confirm the advantages to the patient
of avoiding a laparotomy incision. In the abdominal trial laparo-
scopic hysterectomy was associated with a clinically relevant
higher incidence of major complications and took longer to per-
form. These disadvantages were offset by patient friendly
benefits of less pain, shorter hospital stay, quicker recovery, and
improved quality of life indicators in the short term. The
comparison between laparoscopic and vaginal methods was
underpowered but did not show any significant differences
between the two methods, except that vaginal hysterectomy was
performed in a shorter time.
Table 3 Secondary end points of both trials: minor complications. Values are numbers (percentages) of patients
Abdominal trial Vaginal trial
Abdominal hysterectomy (n=292)
Laparoscopic hysterectomy
(n=584) Vaginal hysterectomy (n=168)
Laparoscopic hysterectomy
(n=336)
Major haemorrhage 3 (1) 8 (1.4) 2 (1.2) 8 (2.4)
Anaesthesia problems 0 (0) 2 (0.3) 1 (0.6) 3 (0.9)
Fever 9 (3.1) 29 (4.9) 12 (7.1) 18 (5.4)
Infection 47 (16.1) 86 (14.7) 24 (14.3) 36 (10.7)
Haematoma 17 (5.8) 25 (4.3) 10 (5.9) 14 (4.2)
Deep vein thrombosis 0 (0) 2 (0.3) 0 0
Other complications 22 (7.5) 40 (6.8) 17 (10.1) 24 (7.1)
At least one minor complication 79 (27.1) 147 (25.2) 47 (27.9) 78 (23.2)
A patient may have had more than one complication.
Table 4 Length of surgery in minutes, from first incision to last suture
Length of surgery
Abdominal trial Vaginal trial
Abdominal hysterectomy (n=292)
Laparoscopic hysterectomy
(n=584) Vaginal hysterectomy (n=168)
Laparoscopic hysterectomy
(n=336)
Median (95% CI) 50 (48 to 53) 84 (80 to 85) 39 (35 to 42) 72 (66 to 77)
Minimum (maximum) 19 (155) 10 (325) 14 (168) 21 (220)
Mean 55.2 85.9 46.6 76.5
Mean difference between trial arms (95%
CI)
−30.7 (−34.9 to −26.4) −29.9 (−35.9 to −23.9)
Table 5 Mean (SD) SF-12 scores (abdominal trial). Difference at each time point
Baseline (n=668) Six weeks (n=449) Four months (n=438) One year (n=478)
Physical component summary*
Abdominal hysterectomy 45.6 (11.5) n=221 41.7 (9.7) n=148 51.6 (8.6) n=134 52.7 (9.3) n=148
Laparoscopic hysterectomy 44.9 (11.7) n=447 46.8 (10.1) n=301 52.6 (8.6) n=304 53.6 (8.4) n=330
Difference (95% CI) 0.6 (−1.2 to 2.5) −5.1 (−7.1 to −3.2) −1.0 (−2.8 to 0.7) −0.9 (−2.5 to 0.8)
P value — <0.001 0.25 0.32
Mental component summary
Abdominal hysterectomy 45.3 (11.3) n=221 51.9 (10.8) n=148 51.8 (9.5) n=134 51.9 (10.2) n=148
Laparoscopic hysterectomy 45.8 (11.7) n=447 50.0 (11.4) n=301 50.9 (10.5) n=304 50.7 (10.7) n=330
Difference (95% CI) −0.5 (−2.4 to 1.4) 1.8 (−0.4 to 4.0) 0.8 (−1.3 to 2.9) 1.1 (−0.9 to 3.2)
P value — 0.11 0.44 0.27
Body image scale results (abdominal trial): mean (SD) and difference at each time point†
Baseline (n=813) 6 weeks (n=529) 4 months (n=505) 1 year (n=555)
Abdominal hysterectomy 9.0 (7.9)(n=270) 5.2 (5.9)(n=172) 4.4 (6.3) n=159 4.1 (5.7)(n=168)
Laparoscopic hysterectomy 8.8 (8.1)(n=540) 3.7 (4.9)(n=357) 3.3 (4.9)(n=346) 3.4 (5.2)(n=387)
Difference (95% CI) 0.2 (−0.9 to 1.4) 1.5 (0.5 to 2.4) 1.1 (0.06 to 2.1) 0.7 (−0.2 to 1.7)
P value — 0.01 0.06 0.13
*A high score represents a better quality of life.
†A low score represents a better body image.
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Laparoscopic hysterectomy is a relatively new approach to
hysterectomy and is infrequently performed in the United King-
dom. In 1995 only 3% of 37 000 hysterectomies in the VALUE
study were performed by this method.21 Both potential
advantages and disadvantages are associated with this approach
compared with the standard approaches of abdominal hysterec-
tomy and vaginal hysterectomy, and these parallel trials
attempted to investigate these differences.
Limitations of the study
Abdominal and vaginal hysterectomy are both commonly
performed; 564 865 were performed in the United States22 and
more than 65 000 in the United Kingdom in 1995.21 Despite this
large number of potential patients we anticipated that recruiting
sufficient numbers of surgeons and patients to this trial would be
difficult. Most gynaecologists have well defined indications for
each approach, and few would feel comfortable in randomising
all patients to any approach. To allow each surgeon to maintain
equipoise and maximise recruitment we designed this study as
two separate but parallel trials. For similar reasons we excluded
some conditions, such as large fibroids, for which most surgeons
would prefer to undertake an abdominal hysterectomy, and
major degrees of uterovaginal prolapse, for which almost all
would undertake a vaginal hysterectomy. This pragmatic
approach excluded many patients and several of the most
important indications for hysterectomy. These decisions will
reduce the generalisability of the study. We believe, however, that
the design maximised recruitment of surgeons and patients and
concentrated the study where the indications as to preferred
method were least clear.
Including unintended laparotomy as a major complication
caused debate in the trial’s steering committee. It represented the
second most common major complication, and a large
proportion of these patients did not have any other
complication. It could be considered that such conversions rep-
resented prudent surgery rather than a major complication.
Excluding them would have substantially reduced the overall
complication rates associated with both laparoscopic hysterec-
tomy and vaginal hysterectomy. We think that on balance they
represented a failure of planned procedure and should be con-
sidered as major complications.
Abdominal versus laparoscopic hysterectomy
The eVALuate study confirmed the results of previous smaller
studies2–11 and showed in the abdominal trial that laparoscopic
hysterectomy caused less pain and was associated with shorter
hospital stay than abdominal hysterectomy. Severity of pain is
difficult to quantify in the postoperative phase. Variable amounts
of several different types of analgesics were taken. We therefore
adjusted pain scores according to the number of days on which
opiates were used, and when we used this measure laparoscopic
hysterectomy in the abdominal trial was still associated with less
pain. Patients undergoing laparoscopic hysterectomy in the
abdominal trial also felt better in the early weeks of
convalescence, as judged by improvements in the physical com-
ponent of the SF-12 and body image scale at six weeks. In the
abdominal trial after laparoscopic hysterectomy sexual activity
habit scores were higher at six weeks than after abdominal
hysterectomy. Overall the compliance with quality of life
questionnaires was excellent, but only 60% (828/1380) of
patients returned questionnaires at all three time points. These
results should therefore be confirmed by others.
The primary end point of the trial was the risk of major com-
plications. In the abdominal trial this study provides strong
evidence of a substantial and clinically relevant increase in the
risk of a major complication associated with laparoscopic hyster-
ectomy compared with abdominal hysterectomy. If the benefits
of the laparoscopic approach are to be realised on a large scale,
it is essential that these risks are widely recognised and additional
techniques and technology to reduce these risks are developed
and evaluated.
Vaginal versus laparoscopic hysterectomy
The vaginal trial was underpowered, and its results are inconclu-
sive. It is, however, still a large trial comparing laparoscopic hys-
terectomy with vaginal hysterectomy. The confidence intervals
around the major complication rates show a possible difference
of 5% in major complication rates in either direction.
Laparoscopic hysterectomy in the vaginal trial took almost twice
as long as vaginal hysterectomy. Our study, however, contained
cases of low technical challenge. Technically more difficult cases
were mostly selected to the abdominal hysterectomy arm, and
this limits generalisability. Unexpected pathology in the vaginal
trial was detected more often during laparoscopic hysterectomy
than vaginal hysterectomy. Even when the indication for the hys-
terectomy was dysfunctional uterine bleeding, additional patho-
logy was found in 5% of patients undergoing vaginal
hysterectomy and 15% of patients undergoing laparoscopic hys-
terectomy. We have no data about whether these findings led to
additional treatment or affected subsequent outcomes. Surgeons
must make a value judgment about whether improved diagnos-
tic accuracy justifies the additional operating time for
laparoscopic hysterectomy.
Prediction of major complications (laparoscopic
hysterectomy)
The study was sufficiently large to indicate an association
between the techniques used for laparoscopic hysterectomy, par-
ticularly those used to secure the ovarian blood vessels, and the
Table 6 Odds ratios and 95% confidence intervals for predictive variables
for laparoscopic hysterectomies
Variable (comparison) Odds ratio (95% CI) P value
Previous pelvic surgery (yes v no) 0.87 (0.56 to 1.33) 0.51
Uterine mobility (fixed v freely
mobile)
1.22 (0.54 to 2.78) 0.64
Vaginal capacity (narrow v
normal, large)
1.91 (0.82 to 4.46) 0.16
Palpable endometriosis (yes v no) 2.31 (0.75 to 7.11) 0.18
Uterine descent (no descent v
first degree)
1.84 (1.05 to 3.21) 0.02
Type of incision:
Laparoscopic hysterectomy v
other
1.08 (0.23 to 5.03) 0.32
Laparoscopic assisted vaginal
hysterectomy v other
1.73 (0.40 to 7.4)
Total laparoscopic
hysterectomy v other
0.90 (0.14 to 5.67)
No of incisions (1-3 v 4-6) 1.08 (0.66 to 1.75) 0.77
Uterine size (per additional week) 1.05 (0.98 to 1.11) 0.15
Maximum intra-abdominal
distension pressure:
≤10 v ≥20 mm Hg 0.91 (0.19 to 4.14) 0.74
11-≤20 v ≥20 mm Hg 1.21 (0.69 to 2.11)
Haemostasis of uterine pedicle:
Bipolar v other 1.65 (0.36 to 7.2) 0.04
Linear stapler v other 1.48 (0.31 to 7.1)
Suture v other 2.89 (0.68 to 12.3)
Haemostasis of ovarian pedicle:
Bipolar v other 1.23 (0.43 to 3.56) <0.001
Linear stapler v other 1.59 (0.53 to 4.79)
Suture v other 7.09 (2.29 to 21.99)
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risk of subsequent major complications. These results should be
confirmed by others.
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What is already known on this topic
Hysterectomy is one of the most often performed of all
major surgical operations
It has traditionally been performed by either the vaginal or
the abdominal method
Either method has advantages and disadvantages, but the
indications for each remain controversial and have never
been compared in a randomised controlled trial
More recently a third method of hysterectomy has been
developed, laparoscopic hysterectomy
What this study adds
Two parallel trials compared the new technique of
laparoscopic hysterectomy to the traditional vaginal and the
abdominal method
The results confirm the advantages to the patient of
avoiding a laparotomy incision
In the abdominal trial laparoscopic hysterectomy was
associated with a clinically relevant higher incidence of
major complications and took longer to perform than the
abdominal method
With laparoscopic hysterectomy, patients have less pain,
shorter hospital stay, quicker recovery, and improved quality
of life indicators in the short term
Vaginal hysterectomy is quicker than laparoscopic
hysterectomy
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Remedial action is necessary if this lack of
professional capacity is common. If it is the problem
could be addressed by brief training courses on
arsenic and public health for all medical practitioners
in Bangladesh. Millions of Bangladeshis may be at risk
of life threatening complications of chronic arsenic
ingestion.
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Perceptions of clinicians and representatives from arsenic mitigation agencies about the
role of doctors in the management of the arsenic problem in Bangladesh
Group 1* Group 2†
Hospital based clinicians (n=42)
Frequency of seeing patients with arsenicosis:
Daily 16 0
One or more cases in a month 4 0
One or more cases in past six months 0 3
Unsure of having seen any arsenicosis patients 0 19
Self reported ability to identify symptoms and signs of arsenicosis:
Adequate 17 4
Inadequate 3 18
Self reported understanding of pathophysiology of arsenicosis:
Adequate 9 1
Incomplete 4 9
Do not know 7 12
Received training or guidelines on managing arsenicosis:
Yes 8 1
No 12 21
Understanding of the nature of the problem:
A public health issue 17 11
Not sure of the nature of the problem 3 11
Involvement in any government arsenic mitigation policy and activity:
Yes 3 0
No 17 22
Representatives from arsenic mitigation agency (n=17)
Role of respondent’s agency in the arsenic mitigation programme:
Patient identification, management, and training of doctors 5
Tube well testing for arsenic, supply of alternative water supply,
increasing awareness of arsenic:
3
Arsenic and other health related research 2
All the above 4
General focus on health and health system 1
Patient identification and applied geology 1
Organising public health professionals 1
Effectiveness of government action on the arsenic problem:
Not effective 7
No comment 10
Perceived problems in mitigation efforts:
Lack of understanding about the public health nature of the problem 7
Lack of proper coordination and poor management 2
Lack of training manpower 2
No emphasis on research activities 1
Centralisation of power and poor governance 1
Misuse of fund on transport and travelling abroad 1
Lack of transparency 1
All above 2
Views on desirable role of doctors in mitigation programmes:
(1) Best practice criteria for clinical management and epidemiology 3
(2) Mass awareness and more training to health workers 1
(3) Knowledge about public health nature and new research 1
(4) Health hazards of alternative technology 1
(5) Invention and validation of alternative technology 1
(6) Responses 1-4 5
(7) Responses 1-5 5
*Clinicians from Dhaka Community Hospital, Dhaka Medical College Hospital, and the Post Graduate Medical
University Hospital, selected because of their known active involvement in care of arsenicosis.
†Clinicians from Sir Salimullah Medical College/Mitford Hospital and Shahid Suhrawardy General Hospital,
selected randomly from staff lists to provide a group of doctors of comparable seniority to doctors in group 1.
Corrections and clarifications
British cancer death rates fell by 12% between 1972
and 2002
Cancer Research UK has alerted us to an error in
the data for female incidence of cancers that it
supplied for the graph in this news article by Zosia
Kmietowicz (7 February, p 303): the male and
female curves for incidence are both correct, but
the female curve should appear for the same
period as the male curve (1975 to 2000). All rates
for incidence and mortality shown on the graph
are for Great Britain.
The eVALuate study: two parallel randomised trials, one
comparing laparoscopic with abdominal hysterectomy, the
other comparing laparoscopic with vaginal hysterectomy
The authors of this paper by Ray Garry and
colleagues appeared in the wrong order (17 January,
pp 129-33). Although the authors submitted the
correct order, this was somehow scrambled by us
during the editorial process—unfortunately our
attempts to unearth how this happened have failed.
The authors should have been listed in the following
order: Ray Garry, Jayne Fountain, Su Mason, Jeremy
Hawe, Vicky Napp, Jason Abbott, Richard Clayton,
Graham Phillips, Mark Whittaker, Richard Lilford,
Stephen Bridgman, Julia Brown.We apologise to the
authors for this mistake.
Measuring the health of nations: analysis of mortality
amenable to health care
The authors of this paper, Ellen Nolte and Martin
McKee, have alerted us to an error in their data
processing, which affects figures 1 and 2 in their
paper (BMJ 2003;327:1129-32). Deaths from colon
cancer had been mistakenly excluded for Denmark,
Finland, Germany, Norway, and Sweden. In figure 1
the standardised death rates for “amenable
mortality” for these countries are 81.43, 71.81,
74.42, 66.50, and 58.46 respectively. In figure 2 the
respective values for “amenable mortality plus
ischaemic heart disease” are 109.29, 114.99, 106.17,
97.09, and 87.50 respectively. In recalculating the
data for those countries, the authors also
discovered a minor miscalculation for the UK
values (which should be 87.46 in figure 1 and
129.98 in figure 2). The revised values slightly affect
the rankings (although not the United Kingdom),
but the authors state that the revisions do not at all
affect the overall conclusion of their paper.
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